Nicardipine Hydrochloride: The First Dihydropyridine Intravenous Calcium-Channel Antagonist

Singh BN Ellrodt G Nademance K . Calcium antagonists: Cardiocirculatory effects and therapeutic applications. In: Hurs JW , ed. Clinical essays on the heart. Vol. 2. New York: McGraw-Hill, 1984: 65–97.

Terai M Takenaka T Maeno H . Inhibition of calcium influx in rabbit aorta by nicardipine hydrochloride (YC-93). Biochem Pharmacol 1981; 30: 375–8.

Bongrani S Razzetti R Schiantarelli P . Cardiovascular effects of nicardipine in anesthetized open-chest dogs in the absence and presence of β-adrenergic receptor blockade: A comparison with nifedipine and verapamil. J Cardiovasc Pharmacol 1985; 7: 899–905.

Tamamura T Konishi T Matsuda H . Electrophysiological effects of nicardipine hydrochloride on the isolated sinoatrial and atrioventricular nodes of the rabbit. Jpn Circ J 1983; 47: 817–23.

Kawai C Konishi T Matsuyama E Okazaki H . Comparative effects of three calcium antagonists, diltiazem, verapamil and nifedipine, on the sinoatrial and atrioventricular nodes; experimental and clinical studies. Circulation 1981; 63: 1035–42.

Nakaya H Kanno M . Effects of nicardipine, a new dihydropyride vasodilator, on coronary circulation and ischemia-induced conduction delay in dogs. Arzneimittelforschung 1982; 32: 626–9.

Horio Y Ono T Rokutanda M . Electrophysiologic effects of nicardipine hydrochloride (YC-93) on the human cardiac conduction system. Kokyu To Junkan 1983; 31: 671–7.

Hashimoto H Asano M Takiguchi Y Katch H Nakashima M . Effects of nicardipine, a dihydropyridine calcium antagonist, on regional myocardial blood flow, myocardial oxygenension and electrical abnormalities during acute coronary artery occlusion in dogs. J Cardiovasc Pharmacol 1985; 7: 613–21.

Takenaka T Usuda S Nomura X Maeno H Sado T . Vasodilator profile of a new 1,4-dihydropyridine derivative, 2, 6-diethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-[2-(N-benzyl-N-methylamino)]-ethyl ester 5-methyl ester hydrochloride (YC93). Arzneimittelforschung 1976; 26: 2172–8.

Duriez PR Adamantidis MM Aniq-Filali O Rouet RH Dupuis BA . Effects de la nicardipine sur les alterations électrophysiologiques et la fruite enzymatique entraînees par l'ischemie myocardique in vitro chez le cobaye. J Pharmacol (Paris) 1985; 16: 75–90.

Abe Y Komori T Miura K . Effects of the calcium antagonist nicardipine on renal function and renin release in dogs. J Cardiovasc Pharmacol 1983; 5: 254–9.

Takenaka T Honda J . Cerebrovascular effects of YC-93, a new vasodilator in dogs, monkeys and human patients. Int J Clin Pharm Biopharm 1979; 17: 1–11.

Iliopoulou A Turner P Warrington SJ . Acute haemodynamic effects of a new calcium antagonist, nicardipine, in man. A comparison with nifedipine. Br J Clin Pharmacol 1983; 15: 59–66.

Baba T Boku A Ishizaki T Sone K Takebe K . Renal effects of nicardipine in patients with mild to moderate essential hypertension. Am Heart J 1986; 111: 552–7.

Silke B Verma SP Hafizullah H . Haemodynamic effects of nicardipine in acute myocardial infarction. Postgrad Med J 1984; 60 (suppl 4): 29–34.

Visser CA Jaarsma W Kan G Kie KI . Immediate and longer-term effects of nicardipine, at rest and during exercise, in patients with coronary artery disease. Postgrad Med J 1984; 60 (suppl 4): 17–20.

Goldberg ME Seltzer JL Halpern N . Nicardipine vs placebo for treatment of postoperative hypertension (abstract). Anesthesiology 1988; 69: A39.

Jackson NC Silke B Verma SP . Haemodynamic effects of intravenous nicardipine during upright exercise in patients with stable angina pectoris. Postgrad Med J 1984; 60 (suppl 4): 11–6.

Sorkin EM Clissold SP . Nicardipine: A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in the treatment of angina pectoris, hypertension and related cardiovascular disorders. Drugs 1987; 33: 296–345.

Silke B Verma SP Frais MA Mafizullah M Taylor SH . Effects of nicardipine on cardiac volume at rest and during exercise-induced angina. Br J Clin Pharmacol 1985; 20 (suppl 1): 169S–76S.

Kakuntani A Bondo S . Effects of vasodilators on regional myocardial function and hemodynamics in experiemental coronary artery occlusion. Shikoku Acta Med 1983; 39: 49–62.

Campbell BC Kelman AW Hillis WS . Non invasive assessment on the haemodynamic effects of nicardipine in normotensive subjects. Br J Clin Pharmacol 1985; 20 (suppl 1): 55S–61S.

Fujita T Noda H . Hemodynamic changes associated with long term antihypertensive therapy with a new calcium antagonist. Jpn Heart J 1983; 24: 587–93.

Jamieson MJ Jeffers TA Dow R Graham D . Nicardipine infusion: Pharmacokinetics, haemodynamics and effects on the systolic time intervals (abstract). Br J Clin Pharmacol 1985; 19: 536P.

Lahiri A Robinson CW Kohli RS Carvana MP Raftery EB . Acute and chronic effects of nicardipine on systolic and diastolic left ventricular performance in patients with heart failure: A pilot study. Clin Cardiol 1986; 9: 257–61.

Silke B Frais MA Verma SP . A review of the haemodynamic effects of nicardipine in ischemic heart disease. Br J Clin Pharmacol 1986; 22: 203S–13S.

Rousseau H Pouleur H . Calcium antagonism free of negative inotropic effects? A comparison of intracoronary nifedipine and nicardipine. Circulation 1984; 70 (suppl II): II–304.

Silke B Verma SP Hussain M . Comparative haemodynamic effects of nicardipine and verapamil in coronary artery disease. Herz 1985b; 10: 112–9.

Higuchi S Shiobara Y . Metabolic fate of nicardipine hydro-chloride, a new vasodilator, by various species in vitro. Xenobiotica 1980; 10: 889–96.

Graham DJM Dow RJ Hall DJ Alexander O Mroszczok EJ Freedman D . The metabolism and pharmacokinetics of nicardipine hydrochloride in man. Br J Clin Pharmacol 1985; 20 (suppl): 23S–8S.

Graham DJM Dow RJ Freedman D Mroszczok E Ling T . Pharmacokinetics of nicardipine following oral and intravenous administration in man. Postgrad Med J 1984; 60 (suppl 4): 7–10.

Dow RJ Graham DJM . A review of the human metabolism and pharmacokinetics of nicardipine hydrochloride. Br J Clin Pharmacol 1986; 22 (suppl): 195S–202S.

Forette F Bellet M Henry JF . Effect of nicardipine in elderly hypertensive patients. Br J Clin Pharmacol 1985; 20 (suppl): 125S–9S.

Lee SM Williams R Warnock D Emmett M Wolbach RA . The effects of nicardipine in hypertensive subjects with impaired renal function. Br J Clin Pharmacol 1986; 22 (suppl): 297S–306S.

Dubois C David D . Nicardipine (N) versus nitroprusside (NP) in the treatment of hypertensive crisis following coronary artery bypass surgery. 2nd Cardiovascular Pharmacotherapy International Symposium San Francisco, CA, 1987.

Benammar MS Coriat P Houissa M . Nicardipine vs Trinitrin for treatment of post-operative hypertension: Effects on hemodynamics and left ventricular function (abstract). Anesthesiology 1987; 67: A139.

Begon C Dartayet B Edouard A David D Samil K . Intravenous nicardipine for treatment of intraoperative hypertension (abstract). Anesthesiology 1987; 67: A39.

Merin RG Chelly JE Hysing ES . Effect of isoflurane (ISO) on nicardipine (NC) pharmacokinetics (PK) (abstract IV-A). Clin Pharmacol Ther 1986; 39: 210.

Chelly JE Hysing ES Merin RG . Role of anesthesia (A) on nicardipine (NC) plasma concentration (PC)-effect relationship (ER) (abstract IV-B). Clin Pharmacol Ther 1986; 39: 186.

Pinaud M Babin M Barnard JM . Systemic hemodynamic effects of deliberate hypotension with nicardipine or sodium nitroprusside during total hip arthroplasty (abstract). Anesthesiology 1988; 69: A37.

Nayler WG Ferrari R Williams A . Protective effect of pretreatment with verapamil, nifedipine and propranolol on mitochondrial function in the ischemic reperfused myocardium. Am J Cardiol 1980; 46: 242–8.

Endo T Nejima J Fujita S . Comparative effects of nicardipine, a new calcium antagonist, on size of myocardial infarction after coronary artery occlusion in dogs. Circulation 1986; 74: 420–30.

Rousseau MF Vincent MF Van Hoof F Van Den Berghe G Chanlier AA Pouleur H . Effect of nicardipine and nisoldipine on myocardial metabolism, coronary blood flow and oxygen supply in angina pectoris. Am J Cardiol 1984C; 54: 1189–94.

Hanet C Rousseau MF Vincent MF . Myocardial protection by intracoronary nicardipine administration during percutaneous transluminal coronary angioplasty. Am J Cardiol 1987; 59: 1035–40.

Antman EM Stone PH Muller JE Braunwald E . Calcium channel blocking agents in the treatment of cadiovascular disorders. Part I: Basic and clinical electrophysiologic effects. Ann Intern Med 1980; 93: 875–85.

Grandy S Bertrand ME Turlapaty P . Effect of intracoronary nicardipine on methylergonovine-induced coronary artery spasm in patients with variant angina (abstract). J Clin Pharmacol 1988; 28: 936.

Shikano K Miyamura K Mizutani T . Prevention of intraoperative and perioperative coronary artery spasm with nicardipine (abstract). J Cardiovasc Surg 1985; 26: 22.

Steen PA Newberg LA Milde JR . Cerebral blood flow and neurologic outcome when nimodipine is given after complete cerebral ischemia in the dog. J Cereb Blood Flow Metab 1984; 4: 82–7.

Flamm ES Adams H Beck D . Dose-escalation study of intravenous nicardipine in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg 1988; 68: 393–400.

Agre K . An overview of the safety and efficacy of nicardipine in clinical trials. A symposium on nicardipine—a vasoselective calcium antagonist. Am J Cardiol 1987; 59: 31S–5S.